ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,196Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 1278

$656K Total Retail Price of All Prescriptions

Rank: 55 out of 1278

919 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 919 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 919 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 8,601 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 741 713 1 2
LISINOPRIL 365 331 2 1
SIMVASTATIN 349 332 3 3
ZOLPIDEM TARTRATE 236 234 4 16
OMEPRAZOLE 202 192 5 6
ATENOLOL 186 181 6 11
HYDROCODONE-ACETAMINOPHEN 186 153 S3 6 7
LOVASTATIN 184 176 8 13
AMLODIPINE BESYLATE 178 164 9 5
SERTRALINE HCL 161 152 10 28
METFORMIN HCL 161 136 10 4
WARFARIN SODIUM 154 143 12 17
METOPROLOL TARTRATE 147 147 13 9
HYDROCHLOROTHIAZIDE 138 135 14 8
ATORVASTATIN CALCIUM 136 125 15 15
CRESTOR 128 121 16 31
PRAVASTATIN SODIUM 125 119 17 14
ALENDRONATE SODIUM 118 115 18 18
TRAMADOL HCL 102 99 19 25
FUROSEMIDE 93 80 20 10
TAMSULOSIN HCL 90 90 21 32
TRIAMTERENE-HCTZ 88 88 22 43
AZITHROMYCIN 84 81 23 37
POTASSIUM CHLORIDE 84 83 23 21
PANTOPRAZOLE SODIUM 83 80 25 34
CELEBREX 81 81 26 87
DIOVAN 80 77 27 44
LOSARTAN POTASSIUM 79 78 28 19
DONEPEZIL HCL 78 78 29 48
PAROXETINE HCL 75 75 30 56
GABAPENTIN 74 71 31 12
LEVOXYL 73 73 32 94
FLUTICASONE PROPIONATE 69 67 33 24
CIPROFLOXACIN HCL 69 66 33 53
PREMARIN 64 63 R 35 119
ALLOPURINOL 62 62 36 36
FENOFIBRATE 60 50 37 47
CITALOPRAM HBR 58 42 38 22
ACTONEL 57 57 39 100
TRAZODONE HCL 56 48 40 38
DOXAZOSIN MESYLATE 53 51 41 69
CLOPIDOGREL 53 53 41 45
GLYBURIDE 52 52 R 43 40
ESTRADIOL 51 50 R 44 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 40 44 30
LOSARTAN-HYDROCHLOROTHIAZIDE 50 49 46 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.